Lec # 2. Animal Biotechnology

Embed Size (px)

Citation preview

  • 7/28/2019 Lec # 2. Animal Biotechnology

    1/22

    Animal Biotechnology

  • 7/28/2019 Lec # 2. Animal Biotechnology

    2/22

    How are transgenic animals produced?

    DNA microinjection

    Introducing the transgene DNA directly into the zygote/Oocyte at an early stageof development.

    No vector required.

    Retrovirus-mediated gene transfer Infecting mouse embryo with a retrovirus which carry the new gene.

    Using virus as a vector.

    Embryonic stem cell-mediated gene transfer The blastocyst (inner layer of a fertilized egg) is harvested

    Mixed with recombinant DNA.

    Inserted back in the blastocyst.

    Sperm-mediated transfer

    Use ofLinkerprotein" to attach the desired genes for particular trait

    The gene with linker proteins are the attach with the sperm which transfer thenew gene to oocyte during fertilization.

  • 7/28/2019 Lec # 2. Animal Biotechnology

    3/22

    Refers to the process of using a glass micropipette to insert the desired

    genetic materials into a single living cell.

    It is a simple mechanical process in which a needle (0.5 to 5m in dia)

    penetrates the cell membrane and/or the nuclear envelope.

    The desired gene(s) are then injected into the nucleus and the needle isremoved.

    Microinjection is normally performed under a specialized optical

    microscope setup called a micromanipulator. The process is frequently

    used as a vector in genetic engineering and transgenics to insert genetic

    material into a single cell.

    Microinjection can also be used in cloning of organisms & in the study of

    cell biology and viruses.

    DNA Microinjection

  • 7/28/2019 Lec # 2. Animal Biotechnology

    4/22

    One of the first methods that proved to be effective in mammals(Gordon and Ruddle, 1981)

    Direct microinjection of a chosen gene construct

    A single gene or a combination of genes, from another memberof the same species or from a different species.

    Into the pronucleus of a fertilized ovum.

    The introduced DNA may lead to the over- or under-expressionof certain genes

  • 7/28/2019 Lec # 2. Animal Biotechnology

    5/22

    The insertion of DNA is random process.

    High probability that the introduced gene will not insert itself into aspecific site on the host DNA.

    Manipulated fertilized ovum is transferred into the oviduct of arecipient female or foster mother.

    Induced to act as a recipient by mating with a vasectomized male.

    Applicable to a wide variety of species.

  • 7/28/2019 Lec # 2. Animal Biotechnology

    6/22

    First Breeding Pair

    Fertile male + superovulated female

    Superovulated female: Immature female induced to

    superovulate Pregnant mares serum on day 1

    Human Chorionic Gonadotropin on day 3

    Mated on day 3

    Fertilized oocytes microinjected on day 4 with foreign DNAconstruct.

    Microinjected oocytes are transferred to the oviducts ofsurrogate mothers at end of day 4.

    Procedure for Producing Transgenic Mice

  • 7/28/2019 Lec # 2. Animal Biotechnology

    7/22

    Second Breeding Pair:

    Sterile male + surrogate mother

    Sterile male produced through vasectomy (A surgical procedure formale sterilization and/orpermanent birth control. During the procedure the entry of sperms is blocked intothe seminal stream)

    Surrogate mother must mate to become a suitable recipient ofinjected eggs

    Mated on day 3

    Microinjected oocytes from first breeding pairare transferred to

    oviducts on day 4 Embryos implant in uterine wall of the surrogate mother and are

    born 19 days later.

    Procedure for Producing Transgenic Mice

  • 7/28/2019 Lec # 2. Animal Biotechnology

    8/22

    Third breeding pair:

    Foster parents (Adoptive)

    Fertile male + female mated to give birth on same day

    surrogate mother. Serves as foster parent if caesarian section (Surgical delivery of an

    infant through an incision in the mother's abdomen) is required for

    surrogate mother.

    Procedure for Producing Transgenic Mice

  • 7/28/2019 Lec # 2. Animal Biotechnology

    9/22

    Establishing transgenic mice

    by DNA microinjection

    Only 5% or less of the treated eggs

    become transgenic progeny

    Need to check mouse pups for DNA

    (PCR or Southern), RNA (Northern or

    RT-PCR) & protein (Western or by

    some specific assay method)

    Expression will vary in transgenic

    offspring: due to position effect and

    copy number

  • 7/28/2019 Lec # 2. Animal Biotechnology

    10/22

    An organism that carries

    a transgene in its germ line &

    can be used in matings to

    establish a pure breeding

    transgenic line or one that act

    as a breeding stock fortransgenic animals

  • 7/28/2019 Lec # 2. Animal Biotechnology

    11/22

  • 7/28/2019 Lec # 2. Animal Biotechnology

    12/22

    The incorporation of injected DNA into the mouse genome cannot

    be tightly controlled. As a result, improper incorporation may

    occur.

    If DNA is incorporated at the 2-cell stage, some cells may expressthe DNA while others will not (mosaic mice).

    If the injected DNA is incorporated in multiple sites, multiple

    copies of the DNA may be expressed leading to overexpression.

    If the DNA copy is not incorporated into the germ line, then it will

    not be passed to offspring.

    Problems with Pronuclear Injection

  • 7/28/2019 Lec # 2. Animal Biotechnology

    13/22

    Less than 5% of

    the microinjected

    fertilized eggs

    become transgenic

    progeny

  • 7/28/2019 Lec # 2. Animal Biotechnology

    14/22

    Retroviral vectors can be used to

    create transgenic animals

    To increase the probability of expression, gene

    transfer is mediated by means of a vector,

    generally a virus.

    Retroviruses are commonly used as vectors to

    transfer genetic material into the cell, taking

    advantage of their ability to infect host cells in

    this way.

    Offspring derived from this method arechimeric, i.e., not all cells carry the retrovirus.

    Transmission of the transgene is possible only

    if the retrovirus integrates into some of the

    germ cells

  • 7/28/2019 Lec # 2. Animal Biotechnology

    15/22

    Genetically engineered

    embryonic stem (ES)

    cells can be used to

    create transgenic animals

    but this method is labor

    intensive & used to

    allow for gene targetingvia homologous

    recombination.

  • 7/28/2019 Lec # 2. Animal Biotechnology

    16/22

    Engineered embryonic stem cellmethod

    Step 1: Get the ES cells

  • 7/28/2019 Lec # 2. Animal Biotechnology

    17/22

    Step 2: Genetically engineer the ES cells

  • 7/28/2019 Lec # 2. Animal Biotechnology

    18/22

    Step 3:

    Place engineered ES

    cells into an earlyembryo

  • 7/28/2019 Lec # 2. Animal Biotechnology

    19/22

    Transgenic mouse: Marathon Mice

    The genetically enhanced

    marathon mice (picture) ran

    twice as far and nearly twice as

    long as ordinary rodents. The

    peroxisome proliferator activated

    receptor (PPAR-delta) gene was

    overexpressed in these transgenic

    mice. The enhanced PPAR-delta

    activity increased fat burning.

  • 7/28/2019 Lec # 2. Animal Biotechnology

    20/22

    Cloning livestock by

    nuclear transfer

  • 7/28/2019 Lec # 2. Animal Biotechnology

    21/22

    Establishing transgenic chickens by

    transfection of isolated blastoderm

    cells Resistance to viral and bacterial

    disease.

    Better feed efficiency.

    Lower fat and cholesterol levelsin eggs.

    Better meat quality.

    Eggs with pharmaceutical

    proteins.

  • 7/28/2019 Lec # 2. Animal Biotechnology

    22/22

    Some human proteins expressed in the mammary

    glands of transgenic animals

    Erythropoietin

    Factor VIII & IX

    Fibrinogen

    Growth hormone

    Hemoglobin Insulin

    Monoclonal antibodies

    Tissue plasminogen activator (TPA)

    Antitrypsin

    Antithrombin III (the first transgenic animal drug, ananticlotting protein, approved by the FDA in 2009)